Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD)

NCT00358436 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

804

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Aclidinium bromide
DRUG: Placebo

Sponsor

AstraZeneca